U.S. Bank, the lead bank of U.S. Bancorp (NYSE: USB), has announced its acquisition of Salucro Healthcare Solutions LLC, a leading provider of healthcare financial technology specializing in patient payments and billing. Based in Tempe, Arizona, Salucro has been at the forefront of online billing and payments solutions for healthcare providers across the United States since its founding in 2004.
Salucro had previously partnered with Elavon, U.S. Bank’s merchant acquiring unit, where its platform was marketed as MedEpay. U.S. Bank initially invested in Salucro in 2022, recognizing the value of its technology in enhancing healthcare payment processes. Now, as a fully integrated part of U.S. Bank, Salucro’s platform will continue to serve healthcare providers through Elavon, one of the largest payments processing companies globally.
“U.S. Bank is a leader in providing banking and payments services to the healthcare industry, making it easier for providers and patients to focus on what’s most important to them,” said Shailesh Kotwal, vice chair of U.S. Bank Payment Services. “Salucro’s robust billing and payment platform is an ideal complement to the offerings we provide through U.S. Bank and Elavon.”
This acquisition underscores U.S. Bank’s longstanding commitment to the healthcare sector, which spans over a century. The bank currently offers a comprehensive suite of banking and payment services to a diverse range of healthcare clients, including hospital systems, insurers, medical equipment manufacturers, and various medical practices. By integrating Salucro’s innovative technology, U.S. Bank aims to further support healthcare organizations in achieving their financial and operational goals, allowing them to concentrate on their primary mission of patient care.
Following the acquisition, Salucro’s team members have joined U.S. Bank and will continue their work under Elavon, further strengthening U.S. Bank’s position in the healthcare payments market.
